Company intelligence / Profile preview

Sanitas Analytica

Ownership: Private
Development stage: Other

Overview

Sanitas Analytica is a multi-disciplinary research group founded in 2021, focused on developing quantitative AI tools to address major healthcare challenges. Their work includes building platforms like Polypharm Solutions for quantifying drug metabolism. The company brings together medical doctors, machine learning experts, and software engineers to create advanced analytical solutions for the life sciences sector.

Therapeutic areas: Metabolic DisordersOther
Modalities: Not specified (likely AI-driven analytics and digital health tools)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Sanitas Analytica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanitas Analytica.

Explore the full profile